All articles

Kymera Achieves Positive STAT6 Protein Degrader Results In Healthy Volunteer Study

Summit Reports Mixed Ivonescimab Data But Path Forward Might Remain

Keros Pulls Final Plug On PAH Drug Cibotercept

iTeos Doubles Down On Strategic Alternatives After TIGIT Failures

Rocket Stock Takes A Dive On Patient Death For Gene Therapy RP-A501

Amazing Survival Feat In Solid Tumors Achieved With Merus Petosemtamab

Sanofi Buys Vigil In $470 Million Deal For Alzheimer’s TREM2 Drug

UroGen Draws A Split Adcom Panel Vote For Bladder Cancer Drug UGN-102

Scroll to Top